205 related articles for article (PubMed ID: 22527886)
21. An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea.
Bäck M; Kumlin M; Cotgreave IA; Dahlén SE
Br J Pharmacol; 2001 Aug; 133(7):1134-44. PubMed ID: 11487525
[TBL] [Abstract][Full Text] [Related]
22. Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing.
Maekawa A; Kanaoka Y; Lam BK; Austen KF
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2256-61. PubMed ID: 11226226
[TBL] [Abstract][Full Text] [Related]
23. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma.
Ravasi S; Capra V; Mezzetti M; Nicosia S; Rovati GE
Mol Pharmacol; 2000 Jun; 57(6):1182-9. PubMed ID: 10825389
[TBL] [Abstract][Full Text] [Related]
24. Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation.
Dartt DA; Hodges RR; Li D; Shatos MA; Lashkari K; Serhan CN
J Immunol; 2011 Apr; 186(7):4455-66. PubMed ID: 21357260
[TBL] [Abstract][Full Text] [Related]
25. The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization.
Hui Y; Yang G; Galczenski H; Figueroa DJ; Austin CP; Copeland NG; Gilbert DJ; Jenkins NA; Funk CD
J Biol Chem; 2001 Dec; 276(50):47489-95. PubMed ID: 11591709
[TBL] [Abstract][Full Text] [Related]
26. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
Bäck M
Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
[TBL] [Abstract][Full Text] [Related]
27. Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors.
Maekawa A; Kanaoka Y; Xing W; Austen KF
Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16695-700. PubMed ID: 18931305
[TBL] [Abstract][Full Text] [Related]
28. Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses.
Maekawa A; Austen KF; Kanaoka Y
J Biol Chem; 2002 Jun; 277(23):20820-4. PubMed ID: 11932261
[TBL] [Abstract][Full Text] [Related]
29. Leukotriene D(4) induces gene expression in human monocytes through cysteinyl leukotriene type I receptor.
Woszczek G; Chen LY; Nagineni S; Kern S; Barb J; Munson PJ; Logun C; Danner RL; Shelhamer JH
J Allergy Clin Immunol; 2008 Jan; 121(1):215-221.e1. PubMed ID: 18028998
[TBL] [Abstract][Full Text] [Related]
30. IFN-gamma induces cysteinyl leukotriene receptor 2 expression and enhances the responsiveness of human endothelial cells to cysteinyl leukotrienes.
Woszczek G; Chen LY; Nagineni S; Alsaaty S; Harry A; Logun C; Pawliczak R; Shelhamer JH
J Immunol; 2007 Apr; 178(8):5262-70. PubMed ID: 17404310
[TBL] [Abstract][Full Text] [Related]
31. Nuclear translocation of cysteinyl leukotriene receptor 1 is involved in oxygen-glucose deprivation-induced damage to endothelial cells.
Fang SH; Lin KN; Huang XQ; Lu YB; Zhang WP; Wei EQ
Acta Pharmacol Sin; 2012 Dec; 33(12):1511-7. PubMed ID: 23085741
[TBL] [Abstract][Full Text] [Related]
32. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist.
Nothacker HP; Wang Z; Zhu Y; Reinscheid RK; Lin SH; Civelli O
Mol Pharmacol; 2000 Dec; 58(6):1601-8. PubMed ID: 11093801
[TBL] [Abstract][Full Text] [Related]
33. The cysteinyl-leukotriene D4 induces cytosolic Ca2+ elevation and contraction of the human detrusor muscle.
Bouchelouche K; Andersen L; Nordling J; Horn T; Bouchelouche P
J Urol; 2003 Aug; 170(2 Pt 1):638-44. PubMed ID: 12853847
[TBL] [Abstract][Full Text] [Related]
34. Eosinophil-derived leukotriene C4 signals via type 2 cysteinyl leukotriene receptor to promote skin fibrosis in a mouse model of atopic dermatitis.
Oyoshi MK; He R; Kanaoka Y; ElKhal A; Kawamoto S; Lewis CN; Austen KF; Geha RS
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4992-7. PubMed ID: 22416124
[TBL] [Abstract][Full Text] [Related]
35. Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists.
Woszczek G; Chen LY; Alsaaty S; Nagineni S; Shelhamer JH
J Immunol; 2010 Feb; 184(4):2219-25. PubMed ID: 20083671
[TBL] [Abstract][Full Text] [Related]
36. Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport.
Moos MP; Mewburn JD; Kan FW; Ishii S; Abe M; Sakimura K; Noguchi K; Shimizu T; Funk CD
FASEB J; 2008 Dec; 22(12):4352-62. PubMed ID: 18779380
[TBL] [Abstract][Full Text] [Related]
37. IL-10 inhibits cysteinyl leukotriene-induced activation of human monocytes and monocyte-derived dendritic cells.
Woszczek G; Chen LY; Nagineni S; Shelhamer JH
J Immunol; 2008 Jun; 180(11):7597-603. PubMed ID: 18490762
[TBL] [Abstract][Full Text] [Related]
38. Differential inhibitory effects of CysLT(1) receptor antagonists on P2Y(6) receptor-mediated signaling and ion transport in human bronchial epithelia.
Lau WK; Chow AW; Au SC; Ko WH
PLoS One; 2011; 6(7):e22363. PubMed ID: 21799837
[TBL] [Abstract][Full Text] [Related]
39. Molecular and functional aspects of human cysteinyl leukotriene receptors.
Capra V
Pharmacol Res; 2004 Jul; 50(1):1-11. PubMed ID: 15082024
[TBL] [Abstract][Full Text] [Related]
40. Intercellular Ca2+ wave propagation involving positive feedback between CRAC channels and cysteinyl leukotrienes.
Di Capite J; Shirley A; Nelson C; Bates G; Parekh AB
FASEB J; 2009 Mar; 23(3):894-905. PubMed ID: 18978154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
